Literature DB >> 20138021

Mitochondria generated nitric oxide protects against permeability transition via formation of membrane protein S-nitrosothiols.

Ana Catarina R Leite1, Helena C F Oliveira, Fabiane L Utino, Rafael Garcia, Luciane C Alberici, Mariana P Fernandes, Roger F Castilho, Aníbal E Vercesi.   

Abstract

Mitochondria generated nitric oxide (NO) regulates several cell functions including energy metabolism, cell cycling, and cell death. Here we report that the NO synthase inhibitors (L-NAME, L-NNA and L-NMMA) administered either in vitro or in vivo induce Ca2+-dependent mitochondrial permeability transition (MPT) in rat liver mitochondria via a mechanism independent on changes in the energy state of the organelle. MPT was determined by the occurrence of cyclosporin A sensitive mitochondrial membrane potential disruption followed by mitochondrial swelling and Ca2+ release. In in vitro experiments, the effect of NOS inhibitors was dose-dependent (1 to 50 microM). In addition to cyclosporin A, L-NAME-induced MPT was sensitive to Mg2+ plus ATP, EGTA, and to a lower degree, to catalase and dithiothreitol. In contrast to L-NAME, its isomer D-NAME did not induce MPT. L-NAME-induced MPT was associated with a significant decrease in both the rate of NO generation and the content of mitochondrial S-nitrosothiol. Acute and chronic in vivo treatment with L-NAME also promoted MPT and decreased the content of mitochondrial S-nitrosothiol. SNAP (a NO donor) prevented L-NAME mediated MPT and reversed the decrease in the rate of NO generation and in the content of S-nitrosothiol. We propose that S-nitrosylation of critical membrane protein thiols by NO protects against MPT.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138021     DOI: 10.1016/j.bbabio.2010.01.034

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

Review 1.  Influence of aging on membrane permeability transition in brain mitochondria.

Authors:  Julia Toman; Gary Fiskum
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

2.  Mitochondrial dysfunction in uremic cardiomyopathy.

Authors:  David Taylor; Sunil Bhandari; Anne-Marie L Seymour
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

Review 3.  Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Authors:  Emanuela Bottani; Costanza Lamperti; Alessandro Prigione; Valeria Tiranti; Nicola Persico; Dario Brunetti
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

Review 4.  Regulation of mitochondrial processes by protein S-nitrosylation.

Authors:  Claude A Piantadosi
Journal:  Biochim Biophys Acta       Date:  2011-03-21

5.  Nitric oxide synthase inhibitors negatively regulate respiration in isolated rodent cardiac and brain mitochondria.

Authors:  Siva S V P Sakamuri; Jared A Sperling; Wesley R Evans; Monica H Dholakia; Aaron L Albuck; Venkata N Sure; Ryousuke Satou; Ricardo Mostany; Prasad V G Katakam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-01-10       Impact factor: 4.733

6.  Diet-sensitive sources of reactive oxygen species in liver mitochondria: role of very long chain acyl-CoA dehydrogenases.

Authors:  Ariel R Cardoso; Pâmela A H B Kakimoto; Alicia J Kowaltowski
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.